Abstract. This study evaluates the correlations between liver histology, cytolysis, cryoglobulinaemia, co-infection with hepatitis B virus, and immunosuppressive treatment in renal transplant patients with HCV infection. Forty-five of 378 kidney recipients
Introduction
It has now been clearly established that hepatitis C virus (HCV) infection can account for a number of hepatic disorders after renal transplantation (RT) [1, 2] . The prevalence of infection following RT ranges from 4 to 50% [3] , and is linked to the prevalence of infection in the population of dialysis patients. The reciprocal consequences of RT on the natural history of the disease and of HCV infection on the graft function are now beginning to be discussed. The aim of this study was to determine the prevalence of HCV infection in a large series of RT patients and to determine the relationships that exist between biochemical liver abnormalities (cytolysis), liver pathology and the presence of cryoglobulinaemia, hepatitis B virus co-infection and immunosuppressive therapy.
Patients and methods
Anti-HCV antibody screening was performed in 378 patients who were transplanted between January 1, 1973 and September 1, 1993. Serological exploration consisted of second generation immunoenzymatic assay (ELISA II, Abbott, Sanofi Pasteur) validated by a confirmation test (RIBAII, Ortho). Anti-HCV-positive patients were explored for anti-HBs, anti-HBc and anti-HBe antibodies and antigens (ELISA). HCV-RNA screening was performed in serum and liver tissue by reverse transcription with DNA amplification techniques (RT-PCR). Liver cytolysis was assessed from the alanine amino transferase (ALT) concentrations (the ALT peak was taken into consideration for statistical regression tests). Liver biopsy puncture (LBP) was systematically performed in patients who were HCV antibody-positive, in search for pathological lesions such as inflammation and necrosis, quantified according to Knodell's modified index: Kl-rated from 0 to 21). Chronic active hepatitis was defined as KI > 5. Cryoglobulinaemia was investigated by immunobinding assay (Hydragel SEBIA) with anti-sera specific for heavy and light chains. The immunosuppressive treatment was as follows: 26 patients (57.7%) were treated with azathioprine (A)-prednisone (P>-cyclosporin (CyA) or A-P and 19 patients were treated with CyA-P. The statistical tests used were the x 2 test fitted for percentage comparisons and the linear regression test to study the correlations between KI and ALT.
Results
Forty-five patients of the 378 had anti-HCV antibodies (prevalence 11.9%). Thirty-eight out of 45 patients Hepatitis C after renal transplantation Comparing between patients with and without chronic active hepatitis (KI >5) revealed that all patients with KI >5 were HCV-RNA-positive (PCR+). The incidence of hepatitis B virus co-infection was the same in both groups. RT duration was significantly longer in patients with chronic active hepatitis (KI >5). The proportion of patients treated with azathioprine was significantly greater in the group of patients with KI > 5 ( Table 1 ). The mean ALT value for the 30 patients biopsied was 62 + 50 Ul/ml (range 12-150). There was a significant correlation between ALT and KI (R = 0.40; P=0.03). Mixed cryoglobulinaemia was detected in 13 patients (28.9%): it was polyclonal anti-IgM IgG form in all cases with a monoclonal component in four cases. The existence of cryoglobulinaemia was significantly more frequent in the PCR + group (12/38 [31.5%] vs 1/7 [14.3%] in the PCR-group, P< 0.0001).
Discussion
The proportion of HCV infection in renal transplantation patients varies from 4% to 50% between teams [1, 3] . In immunocompetent patients, chronic HCV infection is associated to an increased risk of chronic hepatitis, cirrhosis and hepatocellular liver carcinoma [4] . RT justification in patients with HCV chronic hepatitis should consider the consequences of immunosuppression on the prognosis of liver disease. To assess the role of HCV in the development of liver disease, it is necessary to have sufficient prospective follow-up and to repeat liver biopsies. Consistently with data reported by other authors, all patients in our study who had positive PCR exhibited signs of chronic active hepatitis [5] . The results from our study show that liver lesions are aggravated with the duration of RT, which may simply reflect the evolution of liver disease. The data regarding the relationship between biochemical disorders and histological damage are conflicting. Certain authors had established that cytolysis was a 53 poor indicator of the existence of chronic hepatitis in transplanted patients [3, 5] or in healthy blood donors [4] . In our study, we noted a significant correlation between transaminase values and the Knodell score, consistently with Pereira et al. 's findings [6] . Regarding the effect of immunosuppressive treatment on liver histological lesions, we observed a greater proportion of chronic active hepatitis (KI > 5) in patients administered triple therapy. It has been established that the chronic progression of hepatitis C is slower than that of hepatitis B [5] . It has recently been demonstrated that HBV-HCV co-infection had no additional deleterious effect on liver pathology [8] . Our results are not conclusive in that respect because of the small number of B/C virus co-infection observed. Hepatitis C is the first etiological agent of type II cryoglobulinaemia [10] . The occurrence of glomerulonephritis (membrano-proliferative) observed in cryoglobulinaemic HCV-infected patients may be related to the deposition of immunoglobulins in the glomeruli or by the direct cytopathological effect of the virus on renal tissue [11] . It would be interesting to study the prevalence of HCV-linked glomerular diseases in renal transplantation patients, as compared with non transplanted subjects. In our study, cryoglobulin secretion was frequent (28.9%), often oligoclonal and with a monoclonal component in 4 cases. It could be classified as type II-III according to Schifferli's classification [12] . Intermediate oligoclonal forms reflect the disequilibrium between the B and T lymphocytes. The emergence of a B cell clone is probably promoted by acquired immunosuppression in transplanted patients. This monoclonal proliferation should therefore be taken into account in adjusting the intensity of immunosuppressive therapy.
